ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,187Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 1000

$1.11M Total Retail Price of All Prescriptions

Rank: 34 out of 1000

877 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 877 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

20% of this provider’s 877 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

3% of this provider’s 16,648 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,019 611 S3 1 1
SIMVASTATIN 983 708 2 3
LEVOTHYROXINE SODIUM 754 544 3 4
OMEPRAZOLE 671 494 4 2
METFORMIN HCL 667 476 5 8
BENAZEPRIL HCL 604 420 6 61
FUROSEMIDE 438 314 7 7
AMLODIPINE BESYLATE 418 320 8 6
GABAPENTIN 417 273 9 11
PANTOPRAZOLE SODIUM 389 287 10 28
LISINOPRIL 373 259 11 5
MELOXICAM 372 273 12 14
ATORVASTATIN CALCIUM 364 291 13 18
POTASSIUM CHLORIDE 359 261 14 10
GLIMEPIRIDE 355 264 15 34
CARVEDILOL 354 228 16 15
TRAMADOL HCL 339 210 17 13
METOPROLOL TARTRATE 281 230 18 19
PRAVASTATIN SODIUM 262 181 19 12
ATENOLOL 239 175 20 24
HYDROCHLOROTHIAZIDE 234 172 21 9
LOSARTAN POTASSIUM 221 200 22 25
CITALOPRAM HBR 219 119 23 17
ALLOPURINOL 214 147 24 31
SERTRALINE HCL 214 143 24 26
WARFARIN SODIUM 214 157 24 22
NEXIUM 212 155 27 23
AZITHROMYCIN 205 136 28 36
METHOCARBAMOL 204 130 R 29 79
FENOFIBRATE 204 97 29 55
TRAZODONE HCL 200 105 31 29
ZOLPIDEM TARTRATE 194 111 32 16
LOSARTAN-HYDROCHLOROTHIAZIDE 187 125 33 38
SYNTHROID 187 132 33 91
AMLODIPINE BESYLATE-BENAZEPRIL 169 113 35 59
LOVASTATIN 166 119 36 41
PROAIR HFA 161 87 37 50
BENAZEPRIL-HYDROCHLOROTHIAZIDE 157 137 38 175
METFORMIN HCL ER 156 111 39 44
AMITRIPTYLINE HCL 154 113 R 40 45
SPIRIVA 149 122 41 64
ALENDRONATE SODIUM 149 131 41 57
RAMIPRIL 141 93 43 77
TRICOR 141 111 43 141
FLUTICASONE PROPIONATE 136 95 45 40
CLONIDINE HCL 133 93 46 27
CYMBALTA 131 77 47 53
PAROXETINE HCL 130 81 48 63
RANITIDINE HCL 129 108 49 37
PREDNISONE 125 99 50 42
CELEBREX 119 101 51 98
ADVAIR DISKUS 116 88 52 65
METOPROLOL SUCCINATE 113 91 53 21
TIZANIDINE HCL 113 60 53 76
CRESTOR 106 65 55 30
DIGOXIN 105 95 56 52
CYCLOBENZAPRINE HCL 105 30 R 56 39
SPIRONOLACTONE 105 67 56 78
LEVOCETIRIZINE DIHYDROCHLORIDE 96 66 59 187
SULFAMETHOXAZOLE-TRIMETHOPRIM 95 58 60 70
CLOPIDOGREL 94 70 61 35
DILTIAZEM ER 93 81 62 146
MECLIZINE HCL 92 79 63 80
TAMSULOSIN HCL 92 90 63 33
GLIPIZIDE 90 75 65 62
FLUOXETINE HCL 89 37 66 51
CIPROFLOXACIN HCL 89 62 66 46
INDAPAMIDE 88 76 68 164
BUPROPION XL 86 29 69 207
NAMENDA 85 74 70 43
DILTIAZEM 24HR ER 84 73 71 189
LISINOPRIL-HYDROCHLOROTHIAZIDE 83 59 72 20
PLAVIX 80 67 73 49
LYRICA 79 44 74 47
ROPINIROLE HCL 77 43 75 82
ESCITALOPRAM OXALATE 77 42 75 60
HYDRALAZINE HCL 76 60 77 74
SINGULAIR 75 40 78 84
ORPHENADRINE CITRATE 74 27 R 79 393
VENLAFAXINE HCL ER 71 27 80 124
OXYBUTYNIN CHLORIDE 70 47 81 145
NIASPAN 70 51 81 172
AMOXICILLIN 69 42 83 89
DILTIAZEM 24HR CD 68 59 84 136
TRILIPIX 68 44 84 218
DONEPEZIL HCL 67 62 86 32
QUINAPRIL HCL 67 55 86 117
TERAZOSIN HCL 67 61 86 150
ENALAPRIL MALEATE 66 34 89 58
DICLOFENAC SODIUM 65 31 90 123
PROPRANOLOL HCL 63 52 91 135
VESICARE 62 58 92 200
VENTOLIN HFA 62 29 92 83
METOCLOPRAMIDE HCL 61 60 94 99
CARISOPRODOL 61 14 R 94 72
AVODART 61 59 94 214
POLYETHYLENE GLYCOL 3350 60 42 97 69
THEOPHYLLINE ANHYDROUS 59 37 98 186
FLUCONAZOLE 58 21 99 102
MUPIROCIN 58 38 99 140
JANUVIA 57 43 101 85
BISOPROLOL-HYDROCHLOROTHIAZIDE 56 26 102 101
NYSTATIN 55 35 103 182
PROMETHAZINE HCL 55 27 R 103 54
LANTUS SOLOSTAR 55 13 103 120
SUMATRIPTAN SUCCINATE 55 0 103 282
VYTORIN 54 53 107 201
TRIAMTERENE-HCTZ 54 45 107 48
LEVOFLOXACIN 52 33 109 73
BUSPIRONE HCL 51 35 110 110
DIOVAN 51 18 110 67
GLIPIZIDE ER 50 49 112 106
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.